Nivolumab for Newly Diagnosed Advanced-Stage Classic Hodgkin Lymphoma: Safety and Efficacy in the Phase II CheckMate 205 Study (Q92187848)
Jump to navigation
Jump to search
scientific article published on 21 May 2019
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Nivolumab for Newly Diagnosed Advanced-Stage Classic Hodgkin Lymphoma: Safety and Efficacy in the Phase II CheckMate 205 Study |
scientific article published on 21 May 2019 |
Statements
Nivolumab for Newly Diagnosed Advanced-Stage Classic Hodgkin Lymphoma: Safety and Efficacy in the Phase II CheckMate 205 Study (English)
Radhakrishnan Ramchandren
Eva Domingo-Domènech
Antonio Rueda
Marek Trněný
Tatyana A Feldman
Hun Ju Lee
Mariano Provencio
Christian Sillaber
Jonathon B Cohen
Kerry J Savage
Wolfgang Willenbacher
Azra H Ligon
Jing Ouyang
Robert Redd
Scott J Rodig
Mariana Sacchi
Anne Sumbul
Philippe Armand
Stephen M Ansell